Literature DB >> 2059759

Contamination during in vitro processing of bone marrow for transplantation: clinical significance.

H M Lazarus1, M Magalhaes-Silverman, R M Fox, R J Creger, M Jacobs.   

Abstract

We determined the prevalence and clinical significance of positive microbiologic cultures obtained from 194 consecutive bone marrow harvests intended for infusion in 188 consecutive adult bone marrow transplant patients. Microbiologic cultures were obtained at harvest, after manipulation in vitro (for ABO imcompatibility or purging procedures), and at the time of thawing and infusion (after earlier cryopreservation). Only one of 194 marrow harvests was culture-positive intra-operatively (from an ABO-compatible allogeneic marrow that was infused without manipulation). None of 39 other allogeneic marrows (including 21 ABO-incompatible marrows which were manipulated in vitro) and none of 154 autologous marrows (including 40 which were purged in vitro) grew bacteria or fungi. On the other hand, 12 of 153 (8%) bone marrow samples were positive for micro-organisms after thawing at the time of infusion. The predominant organisms cultured were gram negative bacilli (including five Pseudomonas sp.), probably introduced during the thawing process in a water bath. In only one of 13 contaminated marrows was the same organism(s) (Pseudomonas picketti and Pseudomonas paucimobilis) recovered in vivo during the transplant course. This patient experienced a bacteremia which was eradicated without sequelae. Contamination of marrow can occur during the procurement and in vitro handling processes. With proper sterile technique bone marrow infusion does not pose a significant infectious risk for the immunocompromised transplant patient.

Entities:  

Mesh:

Year:  1991        PMID: 2059759

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  7 in total

1.  Effects of storage temperature on hematopoietic stability and microbial safety of BM aspirates.

Authors:  S Hahn; W Sireis; K Hourfar; D Karpova; K Dauber; V A J Kempf; E Seifried; M Schmidt; H Bönig
Journal:  Bone Marrow Transplant       Date:  2013-11-04       Impact factor: 5.483

2.  Packaging Considerations for Biopreservation.

Authors:  Erik J Woods; Sreedhar Thirumala
Journal:  Transfus Med Hemother       Date:  2011-03-16       Impact factor: 3.747

3.  Contamination of bone marrow transplants from peripheral blood.

Authors:  M Farrington; I Matthews; R Marcus; M A Scott; E Caffrey; C J Hunt
Journal:  BMJ       Date:  1994-10-08

4.  Outbreak of Pseudomonas fluorescens bacteremia among oncology patients.

Authors:  P R Hsueh; L J Teng; H J Pan; Y C Chen; C C Sun; S W Ho; K T Luh
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

Review 5.  Cryopreservation as a Key Element in the Successful Delivery of Cell-Based Therapies-A Review.

Authors:  Julie Meneghel; Peter Kilbride; G John Morris
Journal:  Front Med (Lausanne)       Date:  2020-11-26

6.  Native Valve Endocarditis due to Ralstonia pickettii: A Case Report and Literature Review.

Authors:  Joseph Orme; Tomas Rivera-Bonilla; Akil Loli; Negin N Blattman
Journal:  Case Rep Infect Dis       Date:  2015-01-11

7.  Automated dry thawing of cryopreserved haematopoietic cells is not adversely influenced by cryostorage time, patient age or gender.

Authors:  Peter Kilbride; Julie Meneghel; Giovanna Creasey; Fatemeh Masoudzadeh; Tina Drew; Hannah Creasey; David Bloxham; G John Morris; Kevin Jestice
Journal:  PLoS One       Date:  2020-10-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.